T1	Pharmacological_substance 10 24	Chlorpropamide
N1000 	Reference T1 MeSH:D002747	Chlorpropamide
T6	Pharmacological_substance 86 100	chlorpropamide
N1001 	Reference T6 MeSH:D002747	chlorpropamide
T15	Pharmacological_substance 261 275	chlorpropamide
N1002 	Reference T15 MeSH:D002747	chlorpropamide
T16	Pharmacological_substance 308 322	chlorpropamide
N1003 	Reference T16 MeSH:D002747	chlorpropamide
T18	Pharmacological_substance 406 420	chlorpropamide
N1004 	Reference T18 MeSH:D002747	chlorpropamide
T25	Pharmacological_substance 616 630	chlorpropamide
N1005 	Reference T25 MeSH:D002747	chlorpropamide
T27	Pharmacological_substance 661 675	chlorpropamide
N1006 	Reference T27 MeSH:D002747	chlorpropamide
T32	Pharmacological_substance 817 840	2-hydroxychlorpropamide
N1007 	Reference T32 MeSH:C036376	2-hydroxychlorpropamide
T33	Pharmacological_substance 842 861	2-OH-chlorpropamide
T34	Pharmacological_substance 872 897	chlorpropamide metabolite
T41	Pharmacological_substance 1145 1164	2-OH-chlorpropamide
T52	Pharmacological_substance 1325 1344	2-OH-chlorpropamide
T53	Pharmacological_substance 1402 1420	sulfaphenazole,but
T54	Pharmacological_substance 1428 1441	S-mephenytoin
T55	Pharmacological_substance 1443 1455	ketoconazole
N1008 	Reference T55 MeSH:D007654	ketoconazole
T56	Pharmacological_substance 1457 1466	quinidine
N1009 	Reference T56 MeSH:D011802	quinidine
T57	Pharmacological_substance 1471 1482	furafylline
N1010 	Reference T57 MeSH:C050131	furafylline
T61	Pharmacological_substance 1774 1788	chlorpropamide
N1011 	Reference T61 MeSH:D002747	chlorpropamide
T62	Pharmacological_substance 1789 1808	2-OH-chlorpropamide
T66	Pharmacological_substance 2001 2015	chlorpropamide
N1012 	Reference T66 MeSH:D002747	chlorpropamide
T69	Pharmacological_substance 2159 2173	chlorpropamide
N1013 	Reference T69 MeSH:D002747	chlorpropamide
T76	Pharmacological_substance 2303 2317	chlorpropamide
N1014 	Reference T76 MeSH:D002747	chlorpropamide
T38	Subject 696 715	21 healthy subjects
T59	Subject 1348 1353	human
T65	Subject 901 906	human
T77	Subject 1518 1562	eight subjects with the CYP2C9*1/*3 genotype
T78	Subject 1926 1963	13 subjects with CYP2C9*1/*1 genotype
T58	Subject 2051 2098	subjects with the CYP2C19 extensive metabolizer
T64	Subject 2051 2076;2103 2129	subjects with the CYP2C19 poor metabolizer genotypes
T12	Subject 466 471	human
T37	Subject 757 762	human
T39	Subject 1104 1109	human
